by The Scripps Research Institute A biologic (abzyme) developed by Scripps chemists converts the ultra-potent opioid carfentanil (left) to a weaker version (right) by stabilizing the reaction’s transition-state (center). Utilizing abzymes could lead to new ways for treating synthetic opioid overdose. Credit: Kim Janda, PhD, Scripps Research A new therapeutic designed by Scripps Research chemists can alter the molecular structure of...
